Potential Environmental Trigger For Autism, But Only In Genetically Predisposed Individuals
Also Included In: Psychology / Psychiatry; Genetics
Article Date: 08 Jun 2012 - 0:00 PDT
'Potential Environmental Trigger For Autism, But Only In Genetically Predisposed Individuals'
|Patient / Public:|
Psychoactive medications in water affect the gene expression profiles of fathead minnows in a way that mimics the gene expression patterns associated with autism spectrum disorder in genetically susceptible humans, according to research published in the open access journal PLoS ONE. These results suggest a potential environmental trigger for autism spectrum disorder in this vulnerable population, the authors write.
The researchers, led by Michael A. Thomas of Idaho State University, exposed the fish to three psychoactive pharmaceuticals - fluoxetine, a selective serotonin reuptake inhibitor, or SSR1; venlafaxine, a serotonin-norepinephrine reuptake inhibitor, and carbamazepine, used to control seizures - at concentrations comparable to the highest estimated environmental levels.
They found that the only gene expression patterns affected were those associated with idiopathic autism spectrum disorders, caused by genetic susceptibility interacting with unknown environmental triggers. These results suggest that exposure to environmental psychoactive pharmaceuticals may play a role in the development of autism spectrum disorder in genetically predisposed individuals.
Lead researcher Michael A. Thomas remarks, "While others have envisioned a causal role for psychotropic drugs in idiopathic autism, we were astonished to find evidence that this might occur at very low dosages, such as those found in aquatic systems."
Visit our autism section for the latest news on this subject.
Financial Disclosure: MAT was supported by a PhRMA Foundation Sabbatical Fellowship grant, National Institutes of Health Grant Number P20 RR016454 from the INBRE Program of the National Center for Research Resources, and grant number URC-FY2010-05 from the University Research Committee of Idaho State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interest Statement: The authors have declared that no competing interests exist.
Public Library of Science
8 Jun. 2012. <http://www.medicalnewstoday.com/releases/246294.php>
Please note: If no author information is provided, the source is cited instead.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Medical News Today
- Havin' Trouble with CDC Whistleblower, William Thompson - Age of Autism
- Parents airlifted to JMH for injuries - Local 10
- ADHD drugs 'do not stunt children's growth,' say AAP
- Parents flown to Miami hospitals for injuries - Local 10
- Autism Research: August 29,2014 Week In Review - Autism Daily Newscast
- Translational Neurodegeneration Journal Retract Paper on Study of Autism and ... - Autism Daily Newscast
- Organization Offers Tips to Parents of Children with Autism - TWC News
- Prep volleyball: Pawnee City players organize autism fundraiser - Lincoln Journal Star
- Running for Autism Awareness - WXIA-TV
- When You Know You Are Being Lied To……
- Havin' Trouble with CDC Whistleblower, William Thompson
- 20-year-old Woman With Autism Found Safe - TWC News